[
    "**ITC assay: Identification of MBR \\(Minimum",
    "Binding Region) from Nm and Ng.",
    "TIMING 2 days**",
    "1.",
    "WT CaM, Nm and Ng are purified, as described previously<sup>7</sup>.",
    "Prepare 10 \u00b5M of full length Nm/Ng and 150 \u00b5M of CaM in Buffer A \\(20 mM",
    "Imidazole pH 8.0, 100 mM NaCl and 2 mM EGTA). \r\n  ",
    "2. Fill the reference cell with buffer solution, the sample cell with 10 \u00b5M of Nm/Ng full-length protein and syringe with 150 \u00b5M of CaM solution.",
    "For the VP-ITC, the net volume for sample cell and syringe are <sub>1.5 ml and </sub>300 \u03bcl respectively.\r\n  ",
    "3. Use the following conditions: total number of injections \\(30), measurement temperature \\(25\u00b0C), reference power \\(15 \u03bccal s<sup>\u20131</sup>), initial injection delay \\(120 s), stirring speed \\(300 rpm), feedback mode gain \\(high feedback), injection volume \\(10 \u03bcl), duration of each injection \\(10 s), spacing between injections \\(240 s) and filter period \\(2 s).",
    "Start the experiment after gently setting the syringe in place.",
    "In the experiment discussed here, each run will take approximately 4 h. \r\n  **TROUBLESHOOTING**",
    "4.",
    "For ITC experiments with CaM and IQ motif peptides, use 10 \u00b5M of CaM in the cell and 150 \u00b5M of Nm/Ng IQ peptides in the syringe.",
    "Different lengths of Nm and Ng IQ motif peptides \\(Minimum",
    "Binding Region \\(MBR))",
    "were taken for this study.",
    "Dilute 1 mM peptide stock solutions with Buffer A to obtain a 150 \u00b5M final concentration for each peptide.\r\n  ",
    "**DeepView analysis: Computational Analysis using known CaM-IQ motif complex.",
    "Timing 2 h**",
    "5.",
    "Go to this website for the details on DeepView analysis: http://spdbv.vital-it.ch/TheMolecularLevel/SPVTut/ \r\n  6.",
    "At the pdb website \\(www.rcsb.org), search for the template model to design the linked construct, in this case pdb 2IX7.\r\n  ",
    "7. Perform _",
    "In silico_ mutations on the existing motif residues in the template \\(in this case, myosin V IQ motif residues in the pdb 2IX7) with the sequence from MBR of the peptide of interest \\(in this case, Nm/Ng IQ motif).\r\n  ",
    "8.",
    "Once all residues are mutated based on the MBR of the peptide of interest \\(in this case, Nm/Ng IQ motif sequence), use \u201cENERGY MINIMIZATION\u201d to refine the model.\r\n  ",
    "9.  ",
    "Run Pymol and open the models saved and use the \u201cMeasurement\u201d option to measure the distance between the selected terminus of the protein \\(C-terminal, CaM) and the terminus of the peptide \\(N-terminus, Nm). \r\n  ",
    "**Fusion PCR and cloning: Linking MBR to structurally stable protein.",
    "Timing 4 d**",
    "10.",
    "Design four different primers.",
    "In this case, P1- Forward primers for CaM. P2-",
    "Reverse primers for CaM, which incorporates DNA corresponding to \\(Gly)<sub>5</sub> linker at the end of",
    "CaM. P3-",
    "Forward primers for Nm/Ng IQ motifs, incorporating base pairs that correspond to the \\(Gly)<sub>5</sub> linker at the beginning of the Nm/Ng IQ motifs.",
    "P4-",
    "Reverse primers for Nm/Ng IQ motifs.\r\n  ",
    "11.",
    "Set up two sets of PCR reactions.",
    "In this case, one to amplify CaM \\(with P1 and P2 primers) and another for the Nm/Ng IQ motifs \\(with P3 and P4 primers).",
    "Amplify the genes using KAPA Hi-Fi DNA polymerase \\(KAPA Biosystems, MA, USA) according to the manufacturer\u2019s instructions.  \r\n  ",
    "12.",
    "Set-up a PCR reaction \\(25 \u00b5l) to fuse the two genes using genes amplified in the above step as template and P1 and P4 as primers \\(Table 1).",
    "Use the PCR program according to the manufacturer\u2019s instructions.\r\n  13.",
    "Verify the gene fusion using 1.5% agarose gel electrophoresis.",
    "Insert the fused gene into pGS21a \\(Genscript, USA) vector between NdeI and XhoI restriction sites and transform chemically competent _E. coli_ BL21 cells with plasmids positive for the fused gene using heat shock method for protein expression. \r\n  ",
    "**TROUBLESHOOTING**",
    "**Characterization of fused constructs: Purification and characterization of fused complexes \\(CaM-\\(Gly)<sub>5</sub>-NmIQ/NgIQ).",
    "Timing 3-4 d.**",
    "14.",
    "For protein expression, inoculate a single colony in 100 ml of LB medium overnight at 37\u00b0C.",
    "Transfer the inoculum into 1 L of LB media \\(supplemented with 100 \u00b5g/mL ampicillin) and grow the culture at 37\u00b0C until the OD<sub>600</sub> reaches between 0.6\u20130.8.",
    "The culture should then be maintained at 16\u00b0C before protein expression is induced with 0.15 mM IPTG.",
    "Cells are then grown for 16 h at 16\u00b0C.",
    "**CRITICAL STEP** Culture conditions, such as the IPTG concentration and temperature for IPTG induction may vary from protein to protein.  \r\n  ",
    "15.",
    "For Single wavelength Anomalous Dispersion \\(SAD) phasing, seleno-L-methionine \\(SeMet) labeled proteins are produced using LeMaster media<sup>8</sup>.",
    "The same culture conditions as described above are used, with the exception that the LeMaster medium is used and the plasmids are transformed into _E. coli_ DL41 cells \\(Methioine auxotrophic strain).\r\n  ",
    "16.",
    "Resuspend the cell pellet obtained from 1 L culture in 40 ml of lysis buffer \\(50 mM",
    "Tris pH 7.4, 200 mM NaCl, 5% glycerol, 0.1%TritonX, 5 mM Imidazole).",
    "Sonicate the cell suspension and centrifuge the cell lysate at 39,000 xg for 30 min using Avanti J-26 XP centrifuge \\(or similar) to obtain a clear supernatant.",
    "**CRITICAL STEP*",
    "*",
    "Make sure that the tip of the sonicator probe does not touch the sides and bottom of the falcon tube.",
    "Adjust the tube if an unusual loud noise is heard. \r\n  ",
    "17.",
    "Mix the supernatant with 5 ml of Ni-NTA resin that has been pre-equilibrated with lysis buffer and incubate for 1 h to allow binding.",
    "Wash the resin three times and elute the bound proteins using 10 ml of lysis buffer supplemented with 500 mM imidazole. \r\n  ",
    "**TROUBLESHOOTING**",
    "18.",
    "Equilibrate a HiLoad 16/60 Superdex<sup>TM</sup> 75 prep grade \\(GE Healthcare, Life Sciences) column with Buffer A by connecting it to an AKTA purifier.",
    "Inject the protein and run the sample according to the following parameters:  flow rate \\(1 ml/min), column pressure limit \\(0.5 MPa), length of elution \\(1 CV), volume per fraction \\(1 ml).",
    "Start the program to elute the fusion protein in Buffer A. **CRITICAL STEP**",
    "Carry out all the procedures of Ni-NTA chromatography, including this step, at 4\u00b0C. \r\n  ",
    "**TROUBLESHOOTING**",
    "19.",
    "Use 3 kDa cut-off centricons to concentrate the eluted protein.",
    "Pool the fractions and spin it at 4,000 xg at 4\u00b0C until the protein concentration is approximately 12 mg/ml.",
    "**CRITICAL STEP*",
    "*",
    "It is advisable to restrict centrifugation to 30 min and ensure that the concentration is checked.",
    "If necessary, Dynamic Light Scattering \\(DLS) can be performed to verify that concentrating the protein did not deteriorate its homogeneity.\r\n  ",
    "**Structure determination: Crystallization and structural studies of _",
    "apo_-CaM-\\(Gly)<sub>5</sub>-NmIQ and _",
    "apo_-CaM-\\(Gly)<sub>5</sub>-NgIQ.",
    "Timing 4 weeks**",
    "20.",
    "Crystallize _",
    "apo_-CaM-\\(Gly)<sub>5</sub>-NmIQ",
    "and _",
    "apo_-CaM-\\(Gly)<sub>5</sub>-NgIQ using Hanging drop vapor diffusion<sup>9</sup>.",
    "Initial crystals are obtained in a buffer solution consisting 0.2 M magnesium acetate tetrahydrate and 20% w/v polyethylene glycol 3350  for CaM-\\(Gly)<sub>5</sub>-Nm and 0.1 M HEPES sodium solution pH 7.5 and 1.4 M sodium citrate tribasic dehydrate for CaM-\\(Gly)<sub>5</sub>-Ng.",
    "**CRITICAL STEP**",
    "Crystallization conditions vary from case to case.\r\n  ",
    "21.",
    "Improve the quality of the crystals by systematically varying the concentrations of the crystallization buffer components.",
    "Other additives \\(Hampton Research cat.",
    "no.",
    "HR2-428) can also be used<sup>9</sup>. \r\n  ",
    "22.",
    "Collect complete Single wavelength Anomalous Dispersion \\(SAD) datasets at Se peak wavelength \\(0.9795 \u00c5) using the Quantum 4-CCD detector.\r\n  ",
    "23.",
    "Process all the datasets using HKL2000<sup>10</sup> and the .sca files generated are used for locating heavy atom \\(Se) positions, phasing and density modification using ShelxC/D/E<sup>11</sup> from CCP4.",
    "**CRTICAL STEP** Other programs, such as Phenix Autosol, can also be used for heavy atom \\(Se) phasing.",
    "**CRITICAL STEP** Other programs, such as Phenix Autobuild, can also be used for sequence-based model building from heavy atom locations. \r\n  ",
    "24.",
    "Check the model in COOT<sup>12</sup>.",
    "Where necessary, the model can be manually built in COOT.",
    "Stereochemistry of the models obtained are then verified using PROCHECK<sup>13</sup> in CCP4. \r\n  ",
    "**ITC assay: Validation.",
    "Timing 3-4 weeks** ",
    "25.  ",
    "Use Contact run from CCP4 to identify the key interacting residues \\(in this case, from CaM and Nm/Ng IQ motif) involved in interactions and measure the distance between the interacting atoms. \r\n  ",
    "26.",
    "Site-directed mutagenesis of  the interacting residues from the full-length protein can then be performed using Inverse PCR as described in the paper<sup>14</sup>.\r\n  ",
    "**CRITICAL STEP**",
    "In this case, double mutations of CaM were obtained sequentially by performing the second mutation on the plasmid consisting of the first mutation. ",
    "27.",
    "Purify the mutants \\(in this case, CaM, Nm and Ng) as described previously<sup>7</sup>.",
    "Prepare 10 \u00b5M of wild-type \\(WT) and mutants of full-length Nm/Ng in Buffer A to be used in the cell.",
    "Prepare 150 \u00b5M of WT and mutants of the full length protein CaM in Buffer A to be used in the syringe.",
    "For ITC experiments, follow steps 2&3. \r\n  ",
    "28.",
    "Apart from ITC experiments, we used _in vivo_ electrophysiological experiments to validate _in vitro_ findings.",
    "These _in vivo_ experiments are specific to this particular study.",
    "For the details of the electrophysiological experiments, please refer to Kumar et al \\(2013)<sup>7</sup>."
]